Filing Details

Accession Number:
0001209191-15-083316
Form Type:
4
Zero Holdings:
No
Publication Time:
2015-12-03 17:33:13
Reporting Period:
2015-12-01
Filing Date:
2015-12-03
Accepted Time:
2015-12-03 17:33:13
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1142596 Nuvasive Inc NUVA Surgical & Medical Instruments & Apparatus (3841) 330768598
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1289409 Patrick Miles 7475 Lusk Blvd.
San Diego CA 92121
President And Coo No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2015-12-01 981 $52.19 31,646 No 4 S Direct
Common Stock Acquisiton 2015-12-02 3,892 $38.94 35,538 No 4 M Direct
Common Stock Disposition 2015-12-02 3,892 $52.58 31,646 No 4 S Direct
Common Stock Acquisiton 2015-12-02 82,080 $38.94 113,726 No 4 M Direct
Common Stock Disposition 2015-12-02 71,953 $52.48 41,773 No 4 F Direct
Common Stock Disposition 2015-12-03 1,000 $52.53 40,773 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
No 4 M Direct
No 4 S Direct
No 4 M Direct
No 4 F Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Employee Stock Option (Right to Buy) Disposition 2015-12-02 3,892 $0.00 3,892 $38.94
Common Stock Employee Stock Option (Right to Buy) Disposition 2015-12-02 82,080 $0.00 82,080 $38.94
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 2018-01-04 No 4 M Direct
64,028 2018-01-04 No 4 M Direct
Footnotes
  1. Sales effected pursuant to a Rule 10b5-1 Trading Plan adopted by the Reporting Person, which is intended to comply with Rule 10b5-1.
  2. Shares directly held by the Reporting Person. The Reporting Person also holds conditional rights to receive shares pursuant to previously disclosed Company equity awards.
  3. Weighted average sales price from sales transactions ranging from $52.55 to $52.73. Upon request by the Commission staff, the Issuer or a security holder of the Issuer, the Reporting Person will undertake to provide full information regarding the number of shares sold at each separate price.
  4. Payment of exercise price and tax liability by Issuer's withholding of shares incident to the respective option exercise.
  5. Weighted average sales price from sales transactions ranging from $52.45 to $52.63. Upon request by the Commission staff, the Issuer or a security holder of the Issuer, the Reporting Person will undertake to provide full information regarding the number of shares sold at each separate price.
  6. The option, representing a right to purchase a total of 3,892 shares, was granted on January 4, 2008 and is fully vested.
  7. The option, representing a right to purchase a total of 146,108 shares, was granted on January 4, 2008 and is fully vested.